Physical activity and the risk of non-Hodgkin lymphoma subtypes: A pooled analysis.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 02 2023
Historique:
revised: 03 03 2022
received: 14 11 2021
accepted: 21 03 2022
pubmed: 3 9 2022
medline: 17 12 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Non-Hodgkin lymphoma (NHL) is composed of a heterogeneous collection of subtypes with considerable differences in genetics, biology and aetiology. Studies to date on physical activity and NHL risk have not had sufficient sample size to evaluate whether associations differ by subtype. We pooled data from nine case-control studies to examine the association between moderate-to-vigorous intensity physical activity (MVPA) and risk of NHL overall and by subtype (diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukaemia/small lymphocytic lymphoma, marginal zone lymphoma and mature T-cell lymphoma). A total of 5653 cases and 9115 controls were included in the pooled analysis. Physical activity was harmonised across nine studies and modelled as study-specific tertiles. Multinomial logistic regression was used to estimate the association between physical activity and NHL, adjusting for confounders. The overall odds of NHL was 13% lower among participants in the most active tertile of MVPA compared to the least active tertile (adjusted odds ratio = 0.87, 95% CI = 0.80, 0.95). Similar decreases were observed across NHL subtypes. In summary, in this pooled analysis of case-control studies, physical activity was associated with a modest risk reduction for each NHL subtype examined and with overall NHL.

Identifiants

pubmed: 36054546
doi: 10.1002/ijc.34266
doi:

Types de publication

Meta-Analysis Journal Article Research Support, N.I.H., Intramural Research Support, U.S. Gov't, P.H.S. Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

396-407

Subventions

Organisme : CIHR
ID : 300068
Pays : Canada
Organisme : NCI NIH HHS
ID : N01PC35136
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA017054
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA166219
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100555
Pays : United States

Informations de copyright

© 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

World Cancer Research Fund, American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective. Continuous Update Project Expert Report; 2018.
Jochem C, Leitzmann MF, Keimling M, Schmid D, Behrens G. Physical activity in relation to risk of hematologic cancers: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23:833-846.
Pan SY, Morrison H. Physical activity and hematologic cancer prevention. In: Courneya KS, Friedenreich CM, eds. Physical Activity and Cancer. Vol 186. Berlin Heidelberg: Springer; 2011:135-158.
Matthews CE, Moore SC, Arem H, et al. Amount and intensity of leisure-time physical activity and lower cancer risk. J Clin Oncol. 2020;38:686-697.
Davies GA, Strader C, Chibbar R, Papatheodorou S, Dmytriw AA. The relationship between physical activity and lymphoma: a systematic review and meta analysis. BMC Cancer. 2020;20:962.
Psaltopoulou T, Sergentanis TN, Ntanasis-Stathopoulos I, Tzanninis I-G, Riza E, Dimopoulos MA. Anthropometric characteristics, physical activity and risk of hematological malignancies: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2019;145:347-359.
Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Ed.). Lyon: IARC; 2017.
Morton LM, Slager SL, Cerhan JR, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014:130-144.
Kelly JL, Fredericksen ZS, Liebow M, et al. The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol. 2012;22:855-862.
Cerhan JR, Fredericksen ZS, Wang AH, et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet. 2011;2:95-113.
Cerhan JR, Bernstein L, Severson RK, et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control. 2005;16:1203-1214.
Chatterjee N, Hartge P, Cerhan JR, et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomark Prev. 2004;13:1415-1421.
Wang SS, Luo J, Cozen W, et al. Sun sensitivity, indoor tanning and B-cell non-Hodgkin lymphoma risk among Caucasian women in Los Angeles County. Br J Haematol. 2017;177:153-156.
Chiu BC, Kolar C, Gapstur SM, Lawson T, Anderson JR, Weisenburger DD. Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study. Br J Haematol. 2005;128:610-615.
Mikhak B, Bracci PM, Gong Z. Intake of vitamins D and a and calcium and risk of non-Hodgkin lymphoma: San Francisco Bay Area population-based case-control study. Nutr Cancer. 2012;64:674-684.
Boyle T, Gallagher RP, Gascoyne RD, Connors JM, Le ND, Spinelli JJ. Lifetime physical activity and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2015;24:873-877.
Spinelli JJ, Ng CH, Weber JP, et al. Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer J Int Cancer. 2007;121:2767-2775.
Pan SY, Mao Y, Ugnat A-M, Group atCCRER. Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case-control study. Am J Epidemiol. 2005;162:1162-1173.
Kleinstern G, Abu Seir R, Perlman R, et al. Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: a case-control study among Israelis and Palestinians. PLoS One. 2017;12:e0171709.
Solans M, Romaguera D, Gracia-Lavedan E, et al. Adherence to the 2018 WCRF/AICR cancer prevention guidelines and chronic lymphocytic leukemia in the MCC-Spain study. Cancer Epidemiol. 2020;64:101629.
Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.
Long JS, Freese J. Regression Models for Categorical Dependent Variables Using Stata. 3rd ed. College Station, TX: Stata Press; 2014.
Moore SC, Lee I, Weiderpass E, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 2016;176:816-825.

Auteurs

Terry Boyle (T)

Australian Centre for Precision Health, Allied Health and Human Performance, University of South Australia, Adelaide, South Australia, Australia.
Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.
School of Public Health, Curtin University, Perth, Western Australia, Australia.

Geffen Kleinstern (G)

School of Public Health, University of Haifa, Haifa, Israel.

Paige M Bracci (PM)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.

James R Cerhan (JR)

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.

Yolanda Benavente (Y)

Unit of Molecular and Genetic Epidemiology in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Hospitalet De Llobregat, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP, Madrid, Spain.

Delphine Casabonne (D)

Unit of Molecular and Genetic Epidemiology in Infections and Cancer (UNIC-Molecular), Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Hospitalet De Llobregat, Spain.
Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP, Madrid, Spain.

Brian C-H Chiu (BC)

Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA.

Thomas M Habermann (TM)

Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Elizabeth A Holly (EA)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.

Mark Liebow (M)

Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Aaron Norman (A)

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.

Ora Paltiel (O)

Braun School of Public Health and Community Medicine, Hadassah-Hebrew University, Jerusalem, Israel.
Department of Hematology, Hadassah-Hebrew University, Jerusalem, Israel.

Dennis Robinson (D)

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.

Nathaniel Rothman (N)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Rania Abu Seir (R)

Department of Medical Laboratory Sciences, Faculty of Health Professions, Al-Quds University, Palestine.

Susan L Slager (SL)

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.

Paul J Villeneuve (PJ)

School of Mathematics and Statistics and Department of Neuroscience, Carleton University, Ottawa, Ontario, Canada.

Sophia S Wang (SS)

Department of Health Analytics, Division of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope, Duarte, California, USA.

Dennis D Weisenburger (DD)

Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.

John J Spinelli (JJ)

Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH